3D Global Biotech

Taipei, Taiwan Founded: 2014 • Age: 12 yrs
Developer of human tissues and organ reconstructed implants
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About 3D Global Biotech

3D Global Biotech is a company based in Taipei (Taiwan) founded in 2014. 3D Global Biotech operates in a competitive market with competitors including MiMedx Group, Reprise Biomedical, pacifymedical, Rapid Graft and Hans Biomed, among others.

  • Headquarter Taipei, Taiwan
  • Stage Public
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Legal Name 3D Global Biotech Inc.
Operational Areas
Healthcare → Medical Devices & Diagnostics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $265.69 M
    1187.68
    as on Dec 31, 2024
  • Net Profit
    $91.7 M
    0
    as on Dec 31, 2024
  • EBITDA
    $110.33 M
    0
    as on Dec 31, 2024
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of 3D Global Biotech

3D Global Biotech is a publicly listed company on the TPEX with ticker symbol 6808 in Taiwan, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: TPEX · Ticker: 6808 · Sector: Health technology · Taiwan

Funding Insights of 3D Global Biotech

Premium access

Detailed funding history for 3D Global Biotech

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by 3D Global Biotech

Investments
Premium access

Investment portfolio details for 3D Global Biotech

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - 3D Global Biotech

Premium access

Detailed financials for 3D Global Biotech

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

3D Global Biotech Comparisons

3D Global Biotech Primary company
Description
Developer of human tissues and organ reconstructed implants
Location
Taipei, Taiwan
Founded Year
2014
Annual Revenue
$265.69 M
Net Profit
$91.7 M
EBITDA
$110.33 M
Employees
Not available
Premium access

Peer comparison for 3D Global Biotech

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of 3D Global Biotech

3D Global Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MiMedx Group, Reprise Biomedical, pacifymedical, Rapid Graft and Hans Biomed, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics
Locked Locked Locked
Developer of surgical mesh for wound management
Locked Locked Locked
Skin-spraying devices for advanced wound care are developed and manufactured.
Locked Locked Locked
Split-skin grafts are developed for chronic wound treatment.
Locked Locked Locked
Allograft tissues, biomaterials, and skin cell treatments are developed.
Locked Locked Locked
Regenerative medicines from human tissues are developed for multiple diseases.
Premium access

Detailed competitors of 3D Global Biotech

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on 3D Global Biotech

Premium access

Complete news archive for 3D Global Biotech

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about 3D Global Biotech

3D Global Biotech was founded in 2014.

3D Global Biotech is headquartered in Taipei, Taiwan.

3D Global Biotech was founded in 2014 in Taipei, Taiwan, within the biotechnology sector. Human tissues and organ reconstructed implants are developed, with emphasis on soft tissue products and hard tissues. Operations include bone remodeling, bone reconstruction, dental reconstruction, cranioplasty, bio-inks, hydrogels, and corneal epithelial reconstruction. The company operates from its base in Taiwan, targeting regenerative medicine applications.

3D Global Biotech's top competitors include MiMedx Group, Reprise Biomedical and pacifymedical.

Yes, 3D Global Biotech is publicly traded on TPEX under the ticker symbol 6808.

The ticker symbol of 3D Global Biotech is 6808 on TPEX.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available